-Reuters
Baird Initiates Coverage On Parsons Corp with Neutral Rating, Announces Price Target of $50
Baird analyst Andrew Wittmann initiates coverage on Parsons Corp (NYSE:PSN) with a Neutral rating and announces Price Target of $50.
Related Posts
Credit Suisse Upgrades National Health Investors to Neutral, Raises Price Target to $58
Credit Suisse analyst Omotayo Okusanya upgrades National Health Investors (NYSE:NHI) from Underperform to Neutral and raises the price target from $47 to $58.
Ultragenyx Receives Positive Recommendation From NICE In The U.K. For Evkeeza For Adolescents And Adults Aged 12 Years And Older With Homozygous Familial Hypercholesterolemia
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) today announced that the National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending Evkeeza® (evinacumab) to NHS England.
B of A Securities Maintains Neutral on Apple, Lowers Price Target to $154
B of A Securities analyst Wamsi Mohan maintains Apple (NASDAQ:AAPL) with a Neutral and lowers the price target from $160 to $154.